About Contact Us Careers
Sign In

Cell Viability Assays Market - Top Companies and Manufacturers

  • Report ID: 4785
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Companies Dominating the Cell Viability Assays Landscape

    • Thermo Fisher Scientific Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories Inc.
    • Merck KGaA
    • Becton, Dickinson and Company (BD)
    • PerkinElmer Inc.
    • Promega Corporation
    • Biotium, Inc.
    • Creative Bioarray
    • Abcam Plc.
Browse Key Market Insights with Data Illustration:

In the News

  • The improved applied Biosystems HIV-1 Genotyping Kit was released by Thermo Fisher Scientific, Inc. The new kit complements the previously released Applied Biosystems MagMax Viral/Pathogen Nucleic Acid Isolation Kit for HIV-1 Blood Sports. With the aid of this device, labs may monitor HIV mutations to antiretroviral treatment inhibitors using a cutting-edge method for drug resistance surveillance. 
  • The BD Rhapsody TCR/BCR Multiomic Assay, a cutting-edge set of reagents that enables researchers to more easily and thoroughly analyze crucial immune system cells, was released by BD (Becton, Dickinson, and Company), a leading global medical technology company. This assay would then be used to advance research on autoimmune disorders, immune oncology, and infectious diseases.

Author Credits:  Radhika Pawar


  • Report ID: 4785
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cell viability assays is assessed at USD 2 billion.

The cell viability assays market size was over USD 1.87 billion in 2024 and is projected to reach USD 5.6 billion by 2037, witnessing around 8.8% CAGR during the forecast period i.e., between 2025-2037. The market growth can be attributed to growing geriatric population, rise in prevalence of cancer, surge in need for stem cell transplant, and others.

North America industry is set to dominate majority revenue share of 38% by 2037, due to a demand for cell-based therapies in the region.

The major players in the market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company (BD), PerkinElmer Inc., Promega Corporation, Biotium, Inc., Creative Bioarray, Abcam Plc.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample